RS

Rohit Singh

Active Director Director DIN 10085843
DIN 10085843 First appointment Mar 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Rohit Singh

Data last updated:

Rohit Singh is a Director at Oxon Drugs Private Limited (since 2023). The company operates in Paper. Oxon Drugs Private Limited reported revenue of ₹60.6 Lakh (FY 2025).

DIN 10085843
Primary Designation Director
Industry Paper
First Appointment 23 Mar 2023
Oldest Company Age 3 yrs
Largest company Oxon Drugs Private Limited · ₹60.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Oxon Drugs Private Limited U21002HR2023PTC110171
Director23 Mar 20232023₹60.6 Lakh (FY 2025)Active

Board colleagues of Rohit Singh

NameDINCompanyDesignation
Sachin10577601Oxon Drugs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Oxon Drugs Private Limited
Premium access

Shareholding and investment profile for Rohit Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rohit Singh

Rohit Singh currently holds 1 directorship: Oxon Drugs Private Limited (Director, since 23 Mar 2023, revenue ₹60.6 Lakh (FY 2025)).

Rohit Singh was first appointed on 23 Mar 2023 as Director at Oxon Drugs Private Limited.

The current boards of Rohit Singh's companies include Sachin (Oxon Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available